Chronic in vitro ketosis is neuroprotective but not anti-convulsant

Journal of Neurochemistry

Volumn 113, Issue 4, 2010, Pages 826-835

  Samoilova, Marina ^a   Weisspapir, Michael ^a   Abdelmalik, Peter ^a   Velumian, Alexander A ^b,c   Carlen, Peter L ^a,b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

Epilepsy; Hippocampus; Ketogenic diet; Neuroprotection; Organotypic culture

Indexed keywords

3 HYDROXYBUTYRIC ACID; GLUCOSE; KETONE DERIVATIVE; N METHYL DEXTRO ASPARTIC ACID; OXYGEN;

ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; EXCITOTOXICITY; HIPPOCAMPUS; HYPOGLYCEMIA; HYPOXIA; IN VITRO STUDY; KETOGENIC DIET; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; SEIZURE;

3-HYDROXYBUTYRIC ACID; ANIMALS; ANIMALS, NEWBORN; CYTOPROTECTION; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; EPILEPSY; HIPPOCAMPUS; HYPOGLYCEMIA; HYPOXIA-ISCHEMIA, BRAIN; KETOGENIC DIET; KETONE BODIES; KETOSIS; ORGAN CULTURE TECHNIQUES; RATS; RATS, WISTAR; SEIZURES; STRESS, PHYSIOLOGICAL; SYNAPTIC TRANSMISSION;

ANIMALIA;

EID: 77950924405     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2010.06645.x     Document Type: Article

References (109)

1. Abdelmalik P. A., Shannon P., Yiu A. et al. (2007) Hypoglycemic seizures during transient hypoglycemia exacerbate hippocampal dysfunction. Neurobiol. Dis. 26, 646 660. (Pubitemid 46766634)
2. Acharya M. M., Hattiangady B. Shetty A. K. (2008) Progress in neuroprotective strategies for preventing epilepsy. Prog. Neurobiol. 84, 363 404.
3. Appleton D. B. DeVivo D. C. (1974) An animal model for the ketogenic diet. Epilepsia 15, 211 227.
4. Avoli M., D'Antuono M., Louvel J. et al. (2002) Network and pharmacological mechanisms leading to epileptiform synchronization in the limbic system in vitro. Prog. Neurobiol. 68, 167 207.
5. Avoli M., Louvel J., Pumain R. et al. (2005) Cellular and molecular mechanisms of epilepsy in the human brain. Prog. Neurobiol. 77, 166 200. (Pubitemid 41677622)
6. Bach A. Babayan V. (1982) Medium-chain triglycerides: an update. Am. J. Clin. Nutr. 36, 950 962. (Pubitemid 13214366)
7. Ben-Ari Y. Holmes G. L. (2006) Effects of seizures on developmental processes in the immature brain. Lancet Neurol. 5, 1055 1063. (Pubitemid 44709981)
8. Bernard C. (2006) Hippocampal slices: designing and interpreting studies in epilepsy research, in Models of Seizures and Epilepsy (Pitkänen A., Schwartzkroin P. A. Moshé S., eds pp. 59 72. Elsevier Academic Press
9. Boison D. (2008) Adenosine as a neuromodulator in neurological diseases. Curr. Opin. Pharmacol. 8, 2 7. (Pubitemid 351168688)
10. Bough K. J. Rho J. M. (2007) Anticonvulsant mechanisms of the ketogenic diet. Epilepsia 48, 43 58.
11. Bough K. J., Schwartzkroin P. A. Rho J. M. (2003) Calorie restriction and ketogenic diet diminish neuronal excitability in rat dentate gyrus in vivo. Epilepsia 44, 752 760.
12. Bough K. J., Wetherington J., Hassel B. et al. (2006) Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet. Ann. Neurol. 60, 223 235. (Pubitemid 44182397)
13. Buckle P. J. Haas H. L. (1982) Enhancement of synaptic transmission by 4-aminopyridine in hippocampal slices of the rat. J. Physiol. (Lond.) 326, 109 122. (Pubitemid 12117268)
14. DeVivo D. C., Leckie M. P., Ferrendelli J. S. et al. (1978) Chronic ketosis and cerebral metabolism. Ann. Neurol. 3, 331 337.
15. Donevan S. D., White H. S., Anderson G. D. et al. (2003) Voltage-dependent block of N-methyl-D-aspartate receptors by the novel anticonvulsant dibenzylamine, a bioactive constituent of L-(+)-β- hydroxybutyrate. Epilepsia 44, 1274 1279.
16. Doolette D. J. Kerr D. I. B. (1995) Hyperexcitability in CA1 of the rat hippocampal slice following hypoxia or adenosine. Brain Res. 677, 127 137.
17. Dzhala V., Ben-Ari Y. Khazipov R. (2000) Seizures accelerate anoxia-induced neuronal death in the neonatal rat hippocampus. Ann. Neurol. 48, 632 640.
18. Epsztein J., Ben-Ari Y., Represa A. et al. (2008) Late-onset epileptogenesis and seizure genesis: lessons from models of cerebral ischemia. Neuroscientist 14, 78 90.
19. Fowler J. C. (1989) Adenosine antagonists delay hypoxia-induced depression of neuronal activity in hippocampal brain slice. Brain Res. 490, 378 384.
20. Freeman J. M., Kossoff E. H. Hartman A. L. (2007) The ketogenic diet: one decade later. Pediatrics 119, 535 543.
21. Freeman J. M., Vining E. P. G., Kossoff E. H. et al. (2009) A blinded, crossover study of the efficacy of the ketogenic diet. Epilepsia 50, 322 325.
22. Fujiwara N., Higashi H., Shimoji K. et al. (1987) Effects of hypoxia on rat hippocampal neurones in vitro. J. Physiol. (Lond.) 384, 131 151. (Pubitemid 17026513)
23. Gasior M., Rogawski M. A. Hartman A. L. (2006) Neuroprotective and disease-modifying effects of the ketogenic diet. Behav. Pharmacol. 17, 431 439. (Pubitemid 44325805)
24. Gasior M., French A., Joy M. T. et al. (2007) The anticonvulsant activity of acetone, the major ketone body in the ketogenic diet, is not dependent on its metabolites acetol, 1,2-propanediol, methylglyoxal, or pyruvic acid. Epilepsia 48, 793 800. (Pubitemid 46587607)
25. Gribkoff V. K. Bauman L. A. (1992) Endogenous adenosine contributes to hypoxic synaptic depression in hippocampus from young and aged rats. J. Neurophysiol. 68, 620 628.
26. Gueldry S., Marie C., Rochette L. et al. (1990) Beneficial effect of 1,3-butanediol on cerebral energy metabolism and edema following brain embolization in rats. Stroke 21, 1458 1463. (Pubitemid 20339716)
27. Gutnick M. J., Connors B. W. Prince D. A. (1982) Mechanisms of neocortical epileptogenesis in vitro. J. Neurophysiol. 48, 1321 1335.
28. Guzmán M. Blázquez C. (2004) Ketone body synthesis in the brain: possible neuroprotective effects. Prostaglandins Leukot. Essent. Fatty Acids 70, 287 292. (Pubitemid 38200955)
29. Haces M. L., Hernández-Fonseca K., Medina-Campos O. N. et al. (2008) Antioxidant capacity contributes to protection of ketone bodies against oxidative damage induced during hypoglycemic conditions. Exp. Neurol. 211, 85 96.
30. Hansen A. J., Hounsgaard J. Jahnsen H. (1982) Anoxia increases potassium conductance in hippocampal nerve cells. Acta Physiol. Scand. 115, 301 310. (Pubitemid 12061711)
31. Hartman A. L. Vining E. P. G. (2007) Clinical aspects of the ketogenic diet. Epilepsia 48, 31 42.
32. Heinemann U., Kann O. Schuchmann S. (2006) An overview of in vitro seizure models in acute and organotypic slices, in Models of Seizures and Epilepsy (Pitkänen A., Schwartzkroin P. A. Moshé S., eds pp. 35 44. Elsevier Academic Press
33. Isomura Y., Fujiwara-Tsukamoto Y. Takada M. (2008) A network mechanism underlying hippocampal seizure-like synchronous oscillations. Neurosci. Res. 61, 227 233.
34. Izumi Y., Ishii K., Katsuki H. et al. (1998) beta-Hydroxybutyrate fuels synaptic function during development. Histological and physiological evidence in rat hippocampal slices. J. Clin. Invest. 101, 1121 1132. (Pubitemid 28125291)
35. Jefferys J. G. R. (2003) Models and mechanisms of experimental epilepsies. Epilepsia 44, 44 50.
36. Jensen F. E. Wang C. (1996) Hypoxia-induced hyperexcitability in vivo and in vitro in the immature hippocampus. Epilepsy Res. 26, 131 140. (Pubitemid 26420737)
37. Jones R. S. Heinemann U. (1988) Synaptic and intrinsic responses of medical entorhinal cortical cells in normal and magnesium-free medium in vitro. J. Neurophysiol. 59, 1476 1496.
38. Jones R. S. Lambert J. D. (1990) Synchronous discharges in the rat entorhinal cortex in vitro: site of initiation and the role of excitatory amino acid receptors. Neuroscience 34, 657 670. (Pubitemid 20146729)
39. Kashiwaya Y., Takeshima T., Mori N. et al. (2000) D-β- hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease. Proc. Natl Acad. Sci. USA 97, 5440 5444. (Pubitemid 30313737)
40. Katchman A. N. Hershkowitz N. (1993) Adenosine antagonists prevent hypoxia-induced depression of excitatory but not inhibitory synaptic currents. Neurosci. Lett. 159, 123 126. (Pubitemid 23283254)
41. Keene D. L. (2006) A systematic review of the use of the ketogenic diet in childhood epilepsy. Pediatr. Neurol. 35, 1 5. (Pubitemid 43928488)
42. Khazipov R., Congar P. Ben-Ari Y. (1995) Hippocampal CA1 lacunosum-moleculare interneurons: comparison of effects of anoxia on excitatory and inhibitory postsynaptic currents. J. Neurophysiol. 74, 2138 2149.
43. Kim D. Y., Davis L. M., Sullivan P. G. et al. (2007) Ketone bodies are protective against oxidative stress in neocortical neurons. J. Neurochem. 101, 1316 1326.
44. Kohling R. Avoli M. (2006) Methodological approaches to exploring epileptic disorders in the human brain in vitro. J. Neurosci. Methods 155, 1 19. (Pubitemid 43849999)
45. 2+-induced epileptiform activity in organotypic hippocampal slice cultures. Neuroreport 10, 207 213. (Pubitemid 29104788)
46. Kristensen B. W., Noraberg J. Zimmer J. (2001) Comparison of excitotoxic profiles of ATPA, AMPA, KA and NMDA in organotypic hippocampal slice cultures. Brain Res. 917, 21 44. (Pubitemid 32973195)
47. Krnjevic K. (2008) Electrophysiology of cerebral ischemia. Neuropharmacology 55, 319 333.
48. Leblond J. Krnjevic K. (1989) Hypoxic changes in hippocampal neurons. J. Neurophysiol. 62, 1 14. (Pubitemid 19180537)
49. Likhodii S. S. Burnham M. W. (2002) Ketogenic diet: does acetone stop seizures? Med. Sci. Monit. 8, HY19 HY24.
50. Likhodii S. S., Serbanescu I., Cortez M. A. et al. (2003) Anticonvulsant properties of acetone, a brain ketone elevated by the ketogenic diet. Ann. Neurol. 54, 219 226. (Pubitemid 36909620)
51. Lipton P. (1999) Ischemic Cell Death in Brain Neurons. Physiol. Rev. 79, 1431 1568. (Pubitemid 29473320)
52. Liu Y. M. (2008) Medium-chain triglyceride (MCT) ketogenic therapy. Epilepsia 49, 33 36.
53. ATP channels. J. Neurosci. 27, 3618 3625. (Pubitemid 46557685)
54. Maalouf M., Sullivan P. G., Davis L. et al. (2007) Ketones inhibit mitochondrial production of reactive oxygen species production following glutamate excitotoxicity by increasing NADH oxidation. Neuroscience 145, 256 264.
55. Maalouf M., Rho J. M. Mattson M. P. (2009) The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies. Brain Res. Rev. 59, 293 315.
56. Mangan P. S. Kapur J. (2004) Factors underlying bursting behavior in a network of cultured hippocampal neurons exposed to zero magnesium. J. Neurophysiol. 91, 946 957.
57. Masino S. A. Geiger J. D. (2008) Are purines mediators of the anticonvulsant/neuroprotective effects of ketogenic diets? Trends Neurosci. 31, 273 278.
58. Massieu L., Haces M. L., Montiel T. et al. (2003) Acetoacetate protects hippocampal neurons against glutamate-mediated neuronal damage during glycolysis inhibition. Neuroscience 120, 365 378.
59. Masuda R., Monahan J. W. Kashiwaya Y. (2005) D-β-hydroxybutyrate is neuroprotective against hypoxia in serum-free hippocampal primary cultures. J. Neurosci. Res. 80, 501 509.
60. McBain C. J., Boden P. Hill R. G. (1989) Rat hippocampal slices in vitro display spontaneous epileptiform activity following long-term organotypic culture. J. Neurosci. Methods 27, 35 49.
61. Mejía-Toiber J., Montiel T. Massieu L. (2006) D-β- hydroxybutyrate prevents glutamate-mediated lipoperoxidation and neuronal damage elicited during glycolysis inhibition in vivo. Neurochem. Res. 31, 1399 1408.
62. Melø T. M., Nehlig A. Sonnewald U. (2006) Neuronal-glial interactions in rats fed a ketogenic diet. Neurochem. Int. 48, 498 507.
63. Nakase T. Naus C. C. G. (2004) Gap junctions and neurological disorders of the central nervous system. Biochim. Biophys. Acta 1662, 149 158.
64. Neal E. G., Chaffe H., Schwartz R. H. et al. (2008) The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial. Lancet Neurol. 7, 500 506.
65. Neal E. G., Chaffe H., Schwartz R. H. et al. (2009) A randomized trial of classical and medium-chain triglyceride ketogenic diets in the treatment of childhood epilepsy. Epilepsia 50, 1109 1117.
66. Newell D. W., Malouf A. T. Franck J. E. (1990) Glutamate-mediated selective vulnerability to ischemia is present in organotypic cultures of hippocampus. Neurosci. Lett. 116, 325 330.
67. Newell D. W., Barth A., Papermaster V. et al. (1995) Glutamate and non-glutamate receptor mediated toxicity caused by oxygen and glucose deprivation in organotypic hippocampal cultures. J. Neurosci. 15, 7702 7711.
68. Noh H. S., Kim Y. S., Lee H. P. et al. (2003) The protective effect of a ketogenic diet on kainic acid-induced hippocampal cell death in the male ICR mice. Epilepsy Res. 53, 119 128.
69. Noh H. S., Lee H. P., Kim D. W. et al. (2004) A cDNA microarray analysis of gene expression profiles in rat hippocampus following a ketogenic diet. Mol. Brain Res. 129, 80 87.
70. Noh H. S., Hah Y.-S., Nilufar R. et al. (2006) Acetoacetate protects neuronal cells from oxidative glutamate toxicity. J. Neurosci. Res. 83, 702 709.
71. Noraberg J., Poulsen F. R., Blaabjerg M. et al. (2005) Organotypic hippocampal slice cultures for studies of brain damage, neuroprotection and neurorepair. Curr. Drug Targets CNS Neurol. Disord. 4, 435 452.
72. Perez Velazquez J. L. Carlen P. L. (2000) Gap junctions, synchrony and seizures. Trends Neurosci. 23, 68 74.
73. Perreault P. Avoli M. (1989) Effects of low concentrations of 4-aminopyridine on CA1 pyramidal cells of the hippocampus. J. Neurophysiol. 61, 953 970.
74. Perreault P. Avoli M. (1991) Physiology and pharmacology of epileptiform activity induced by 4-aminopyridine in rat hippocampal slices. J. Neurophysiol. 65, 771 785.
75. Pringle A. K., Iannotti F., Wilde G. J. C. et al. (1997) Neuroprotection by both NMDA and non-NMDA receptor antagonists in in vitro ischemia. Brain Res. 755, 36 46.
76. Prins M. L. (2008) Cerebral metabolic adaptation and ketone metabolism after brain injury. J. Cereb. Blood Flow Metab. 28, 1 16.
77. Rho J. M., Kim D. W., Robbins C. A. et al. (1999) Age-dependent differences in flurothyl seizure sensitivity in mice treated with a ketogenic diet. Epilepsy Res. 37, 233 240.
78. Rho J. M., Anderson G. D., Donevan S. D. et al. (2002) Acetoacetate, acetone, and dibenzylamine (a contaminant in L-(+)-β-hydroxybutyrate) exhibit direct anticonvulsant actions in vivo. Epilepsia 43, 358 361.
79. Rutecki P. A., Lebeda F. J. Johnston D. (1987) 4-Aminopyridine produces epileptiform activity in hippocampus and enhances synaptic excitation and inhibition. J. Neurophysiol. 57, 1911 1924.
80. Samoilova M., Wentlandt K., Adamchik Y. et al. (2008) Connexin 43 mimetic peptides inhibit spontaneous epileptiform activity in organotypic hippocampal slice cultures. Exp. Neurol. 210, 762 775.
81. Schiff S. J. Somjen G. G. (1985) Hyperexcitability following moderate hypoxia in hippocampal tissue slices. Brain Res. 337, 337 340.
82. Schuchmann S., Meierkord H., Stenkamp K. et al. (2002) Synaptic and nonsynaptic ictogenesis occurs at different temperatures in submerged and interface rat brain slices. J. Neurophysiol. 87, 2929 2935.
83. Schwartzkroin P. A. Prince D. A. (1980) Changes in excitatory and inhibitory synaptic potentials leading to epileptogenic activity. Brain Res. 183, 61 76.
84. Sick T. J., Solow E. L. Roberts E. L. (1987) Extracellular potassium ion activity and electrophysiology in the hippocampal slice: paradoxical recovery of synaptic transmission during anoxia. Brain Res. 418, 227 234.
85. Sims N. R. Heward S. L. (1994) Delayed treatment with 1,3-butanediol reduces loss of CA1 neurons in the hippocampus of rats following brief forebrain ischemia. Brain Res. 662, 216 222.
86. Sokoloff L. (1973) Metabolism of ketone bodies by the brain. Ann. Rev. Med. 24, 271 280.
87. Stafstrom C. E. (1999) Animal models of the ketogenic diet: what have we learned, what can we learn? Epilepsy Res. 37, 241 259.
88. Stafstrom C. E., Wang C. Jensen F. E. (1999) Electrophysiological observations in hippocampal slices from rats treated with the ketogenic diet. Dev. Neurosci. 21, 393 399.
89. Sullivan P. G., Rippy N. A., Dorenbos K. et al. (2004) The ketogenic diet increases mitochondrial uncoupling protein levels and activity. Ann. Neurol. 55, 576 580.
90. Suzuki M., Suzuki M., Sato K. et al. (2001) Effect of ß-hydroxybutyrate, a cerebral function improving agent, on cerebral hypoxia, anoxia and ischemia in mice and rats. Jpn. J. Pharmacol. 87, 143 150.
91. Suzuki M., Suzuki M., Kitamura Y. et al. (2002) β-hydroxybutyrate, a cerebral function improving agent, protects rat brain against ischemic damage caused by permanent and transient focal cerebral ischemia. Jpn. J. Pharmacol. 89, 36 43.
92. Tancredi V., Avoli M. Hwa G. G. (1988) Low-magnesium epilepsy in rat hippocampal slices: inhibitory postsynaptic potentials in the CA1 subfield. Neurosci. Lett. 89, 293 298.
93. Tasker R. C., Coyle J. T. Vornov J. J. (1992) The regional vulnerability to hypoglycemia-induced neurotoxicity in organotypic hippocampal culture: protection by early tetrodotoxin or delayed MK-801. J. Neurosci. 12, 4298 4308.
94. Thio L. L., Wong M. Yamada K. A. (2000) Ketone bodies do not directly alter excitatory or inhibitory hippocampal synaptic transmission. Neurology 54, 325 331.
95. Tieu K., Perier C., Caspersen C. et al. (2003) D-β-hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease. J. Clin. Invest. 112, 892 901.
96. 2+in the rat hippocampal slice. J. Physiol. (Lond.) 478 (Pt 3 379 393.
97. Traub R. D., Bibbig A., LeBeau F. E. N. et al. (2004) Cellular mechanisms of neuronal population oscillations in the hippocampus in vitro. Annu. Rev. Neurosci. 27, 247 278.
98. Vamecq J., Vallee L., Lesage F. et al. (2005) Antiepileptic popular ketogenic diet: emerging twists in an ancient story. Prog. Neurobiol. 75, 1 28.
99. Veech R. L. (2004) The therapeutic implications of ketone bodies: The effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism. Prostaglandins Leukot. Essent. Fatty Acids 70, 309 319.
100. Veech R. L., Chance B., Kashiwaya Y. et al. (2001) Ketone bodies, potential therapeutic uses. IUBMB Life 51, 241 247.
101. Wada H., Okada Y., Nabetani M. et al. (1997) The effects of lactate and β-hydroxybutyrate on the energy metabolism and neural activity of hippocampal slices from adult and immature rat. Brain Res. Dev. Brain Res. 101, 1 7.
102. Walther H., Lambert J. D., Jones R. S. et al. (1986) Epileptiform activity in combined slices of the hippocampus, subiculum and entorhinal cortex during perfusion with low magnesium medium. Neurosci. Lett. 69, 156 161.
103. Whittington M. A., Traub R. D. Jefferys J. G. (1995) Erosion of inhibition contributes to the progression of low magnesium bursts in rat hippocampal slices. J. Physiol. (Lond.) 486, 723 734.
104. Wilson W. A., Swartzwelder H. S., Anderson W. W. et al. (1988) Seizure activity in vitro: a dual focus model. Epilepsy Res. 2, 289 293.
105. Yamada K. A., Rensing N. Thio L. L. (2005) Ketogenic diet reduces hypoglycemia-induced neuronal death in young rats. Neurosci. Lett. 385, 210 214.
106. Yudkoff M., Daikhin Y., Melø T. M. et al. (2007) The ketogenic diet and brain metabolism of amino acids: relationship to the anticonvulsant effect. Annu. Rev. Nutr. 27, 415 430.
107. Zhu P. J. Krnjevic K. (1997) Adenosine release mediates cyanide-induced suppression of CA1 neuronal activity. J. Neurosci. 17, 2355 2364.
108. Zhu P. J. Krnjevic K. (1999) Persistent block of CA1 synaptic function by prolonged hypoxia. Neuroscience 90, 759 770.
109. Ziegler D. R., Ribeiro L. C., Hagenn M. et al. (2003) Ketogenic diet increases glutathione peroxidase activity in rat hippocampus. Neurochem. Res. 28, 1793 1797.